SLC39A1 and gastric cancer: Higher expression of SLC39A1, 5–7, and 9 indicated better OS, FPS, and PPS, and increased SLC39A2–4, 8, and SLC39A10 expression indicated poor OS, FP, and PPS in the patients with gastric cancer (Ding et al., 2019).